InvestorBrandNetworknews

WashU Vaccine Could Revolutionize Personalized Glioblastoma Treatment

Tuesday, June 23, 2026IBN.aiView original
Researchers at Washington University (WashU) Medicine have conducted a small clinical trial testing a new vaccine against glioblastoma. The formulation was administered to nine patients who had undergone surgery and chemo-radiation therapy to remove their tumors. The results of this study show promise in extending tumor-free survival for a disease that is currently hard to treat.  For now, […]